| PNR |
Report |
Q2 2026 adjusted EPS |
IN-LINE |
pred ~$1.12 vs. cons $1.12 |
HIGH |
| PNR |
Report |
Q2 2026 revenue |
IN-LINE |
pred ~$930M vs. cons $930M |
HIGH |
| PNR |
Report |
Q2 2026 adjusted operating income |
IN-LINE |
pred ~$235M vs. cons $235M |
HIGH |
| PNR |
Guide |
Adjusted EPS guidance |
UNCHANGED |
guide ~$4.70 vs. cons $4.70 (FY2026) |
HIGH |
| PNR |
Guide |
Revenue growth guidance |
UNCHANGED |
guide ~-5.5% vs. cons -5.5% (FY2026) |
HIGH |
| PNR |
Guide |
Adjusted operating income guidance |
UNCHANGED |
guide ~$980M vs. cons $980M (FY2026) |
MEDIUM |
| PNR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
MEDIUM |
| PNR |
Return |
5-day cumulative residual |
+0.5% (FADE) |
A clean reaffirmation after the approximately 16% preannouncement selloff should drive an initial relief move, but FY2026 EPS remains ~$4.70 versus the former ~$5.35 midpoint and the implied second-half Pool destocking remains ~$80M of sales, limiting upward revisions and causing most of the day-1 gain to fade. |
MEDIUM |